Resource Central is a product of the Pediatric Pandemic Network.
  1. Home
  2. Resources
  3. Beyfortus vs. Synagis for RSV Prevention in Children: 6 Differences Parents Should Know

Beyfortus vs. Synagis for RSV Prevention in Children: 6 Differences Parents Should Know

  • 2024
  • Alyssa Billingsley; Patricia Pinto-Garcia

    • Access Resources

    • SummaryEN
    • Ask aRCie Ask aRCie About This Resource

    About

    This website describes the differences between Beyfortus and Synagis, two injections used to prevent RSV in children. Beyfortus is recommended for more infants and lasts the entire RSV season with one dose, while Synagis requires monthly doses. Both are monoclonal antibodies but target different parts of the virus. Beyfortus provides higher levels of protection and is available through a program that offers it for free to eligible children. Side effects are generally mild for both medications, including injection site reactions and possible allergic responses. Parents should consult healthcare providers about which option is best for their child.

    Tags

    More like this

    Vaccine Education Center None · Children's Hospital of Philadelphia Pertussis (Whooping Cough) 2024 · Pediatric Pandemic Network (PPN) G7 Major Initiatives None · Gulf 7 - Pediatric Disaster Network (G7)
    The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Access Resources

  • SummaryEN
  • Ask aRCie Ask aRCie About This Resource